Seeman P, Ohara K, Ulpian C, Seeman M V, Jellinger K, Van Tol H H, Niznik H B
Department of Pharmacology, Clarke Institute of Psychiatry, University of Toronto, Ontario, Canada.
Neuropsychopharmacology. 1993 Feb;8(2):137-42. doi: 10.1038/npp.1993.15.
Because dopamine (DA) D2 receptors are a target in neuroleptic therapy and have been found to be elevated in schizophrenia, the human DA D2 receptor gene was examined for possible abnormalities in schizophrenia. Moreover, since D2 receptors in psychosis have a reduced coupling to D1 receptors, the cytoplasmic third loop of D2 was chosen for deoxyribonucleic acid (DNA) sequencing, since this region is essential for coupling to G-proteins. This region also contains exon 5, which is expressed in the long form of D2, but not in the short form of D2. In eight schizophrenia cases, this region had normal exon sequences (exons 4, 5 and 6), and normal sequences at its intron-exon junctions. However, exon 6 contained three DNA polymorphic base changes, and introns 4 and 5 revealed three missing bases and two polymorphic base changes, none of which would be expected to alter the D2 receptor protein in schizophrenia.
由于多巴胺(DA)D2受体是抗精神病药物治疗的靶点,且已发现其在精神分裂症患者中表达上调,因此对人类DA D2受体基因进行检测,以探寻精神分裂症患者中可能存在的异常情况。此外,由于精神病患者体内的D2受体与D1受体的偶联减少,因此选择对D2受体的胞质第三环进行脱氧核糖核酸(DNA)测序,因为该区域对于与G蛋白的偶联至关重要。该区域还包含外显子5,其在D2的长形式中表达,但在D2的短形式中不表达。在8例精神分裂症患者中,该区域的外显子序列(外显子4、5和6)正常,内含子 - 外显子连接处的序列也正常。然而,外显子6包含三个DNA多态性碱基变化,内含子4和5显示有三个碱基缺失和两个多态性碱基变化,预计这些变化均不会改变精神分裂症患者体内的D2受体蛋白。